Buprenorphine QI · Medical director findings

Medical Director Summary — 2026-1Q

In 2026-1Q, 155 age-eligible records were reviewed (16 with undocumented age included, 10 confirmed under 16 excluded). 0 received naloxone and 0 (0.0%) improved. Of 0 candidates with drug-use indicators, 0 had a documented exclusion, leaving 0 buprenorphine-eligible patients; 0 (0.0%) received buprenorphine and 0 were true missed opportunities. 0 had buprenorphine considered but not given (pertinent-negative). COWS was documented in 48 of 155 eligible records (31.0%); age was documented on 90.3%.

Focus Areas This Quarter

Action Items

COWS documentation (31.0%) is below the 80% target.

Age documentation (90.3%) below 95% — 16 records could not be age-screened.

Quarter-over-Quarter Change — 2025-4Q → 2026-1Q

Trend vs Prior Quarter

COWS documentation improved ▲ 10.2 pts (20.8% → 31.0%)

Bupe when eligible held steady ▬ 0 pts (0% → 0%)

Buprenorphine given unchanged ▬ 0 (0 → 0)

Missed opportunities unchanged ▬ 0 (0 → 0)

Eligible records rose ▲ 11 (144 → 155)

Candidates unchanged ▬ 0 (0 → 0)